Skip Nav Destination
Venetoclax after idelalisib: relevant progress for CLL
Venetoclax for patients with chronic lymphocytic leukemia who progressed during or after idelalisib therapy
Issue Archive
Table of Contents
EDITORIAL
BLOOD COMMENTARIES
CLINICAL TRIALS AND OBSERVATIONS
Venetoclax after idelalisib: relevant progress for CLL
Clinical Trials & Observations
PLENARY PAPER
MYELOID NEOPLASIA
Glutaminolysis is a metabolic dependency in FLT3ITD acute myeloid leukemia unmasked by FLT3 tyrosine kinase inhibition
Paolo Gallipoli,George Giotopoulos,Konstantinos Tzelepis,Ana S. H. Costa,Shabana Vohra,Paula Medina-Perez,Faisal Basheer,Ludovica Marando,Lorena Di Lisio,Joao M. L. Dias,Haiyang Yun,Daniel Sasca,Sarah J. Horton,George Vassiliou,Christian Frezza,Brian J. P. Huntly
REVIEW SERIES
CLINICAL TRIALS AND OBSERVATIONS
Venetoclax for patients with chronic lymphocytic leukemia who progressed during or after idelalisib therapy
Clinical Trials & Observations
Steven Coutre,Michael Choi,Richard R. Furman,Herbert Eradat,Leonard Heffner,Jeffrey A. Jones,Brenda Chyla,Lang Zhou,Suresh Agarwal,Tina Waskiewicz,Maria Verdugo,Rod A. Humerickhouse,Jalaja Potluri,William G. Wierda,Matthew S. Davids
HEMATOPOIESIS AND STEM CELLS
Canonical Notch signaling is dispensable for adult steady-state and stress myelo-erythropoiesis
Sara Duarte,Petter S. Woll,Natalija Buza-Vidas,Desmond Wai Loon Chin,Hanane Boukarabila,Tiago C. Luís,Laura Stenson,Tiphaine Bouriez-Jones,Helen Ferry,Adam J. Mead,Deborah Atkinson,Shaobo Jin,Sally-Ann Clark,Bishan Wu,Emmanouela Repapi,Nicki Gray,Stephen Taylor,Anders P. Mutvei,Yat Long Tsoi,Claus Nerlov,Urban Lendahl,Sten Eirik W. Jacobsen
IMMUNOBIOLOGY AND IMMUNOTHERAPY
MYELOID NEOPLASIA
LSD1 inhibition exerts its antileukemic effect by recommissioning PU.1- and C/EBPα-dependent enhancers in AML
Monica Cusan,Sheng F. Cai,Helai P. Mohammad,Andrei Krivtsov,Alan Chramiec,Evangelia Loizou,Matthew D. Witkin,Kimberly N. Smitheman,Daniel G. Tenen,Min Ye,Britta Will,Ulrich Steidl,Ryan G. Kruger,Ross L. Levine,Hugh Y. Rienhoff, Jr,Richard P. Koche,Scott A. Armstrong
TRANSPLANTATION
Murine chronic graft-versus-host disease proteome profiling discovers CCL15 as a novel biomarker in patients
Jing Du,Ryan Flynn,Katelyn Paz,Hong-Gang Ren,Yuko Ogata,Qing Zhang,Philip R. Gafken,Barry E. Storer,Nathan H. Roy,Janis K. Burkhardt,Wendy Mathews,Jakub Tolar,Stephanie J. Lee,Bruce R. Blazar,Sophie Paczesny
LETTERS TO BLOOD
BLOOD WORK
-
Cover Image
Cover Image
Confocal microscopy of cGVHD mouse spleen demonstrates expression of CCL9 (red) by the vessel areas, but not by germinal center (gray) or CD11b+ myeloid cells (green). See the article by Du et al on page 1743.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals